Lyrica CR (pregabalin extended-release tablets - Pfizer, generic) — Cigna
Postherpetic neuralgia
Preferred products
- gabapentin immediate-release (brand [Neurontin] or generic)
- generic immediate-release pregabalin
- generic pregabalin extended-release tablets
Initial criteria
- Patient has tried gabapentin immediate-release (brand [Neurontin] or generic) OR generic immediate-release pregabalin; AND
- If brand Lyrica CR is requested, patient has tried generic pregabalin extended-release tablets; AND
- If brand Lyrica CR is requested, patient cannot continue to use the generic due to a formulation difference in the inactive ingredient(s) [e.g., differences in dyes, fillers, preservatives] between the brand and the bioequivalent generic product, which, according to the prescriber, would result in a significant allergy or serious adverse reaction
Approval duration
1 year